{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:15:26Z","timestamp":1778861726617,"version":"3.51.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biochem"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2091-15-9","type":"journal-article","created":{"date-parts":[[2014,4,7]],"date-time":"2014-04-07T19:41:20Z","timestamp":1396899680000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Plasmodium falciparum UvrD activities are downregulated by DNA-interacting compounds and its dsRNA inhibits malaria parasite growth"],"prefix":"10.1186","volume":"15","author":[{"given":"Mohammed","family":"Tarique","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farha","family":"Tabassum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moaz","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renu","family":"Tuteja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Malaria Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,3]]},"reference":[{"issue":"4","key":"449_CR1","doi-asserted-by":"publisher","first-page":"350","DOI":"10.4161\/cib.20005","volume":"5","author":"M Ahmad","year":"2012","unstructured":"Ahmad M, Tuteja R: Plasmodium falciparum RuvB proteins: emerging importance and expectations beyond cell cycle progression. Commun Integr Biol. 2012, 5 (4): 350-361. 10.4161\/cib.20005.","journal-title":"Commun Integr Biol"},{"key":"449_CR2","volume-title":"World-Malaria-Report","author":"WHO","year":"2012","unstructured":"WHO: World-Malaria-Report. 2012,\nhttp:\/\/www.who.int\/malaria\/publications\/world_malaria_report_2012\/en\/index.html\n,"},{"issue":"9814","key":"449_CR3","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(12)60034-8","volume":"379","author":"CJ Murray","year":"2012","unstructured":"Murray CJ, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, Haring D, Fullman N, Naghavi M, Lozano R, Lopez AD: Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet. 2012, 379 (9814): 413-431. 10.1016\/S0140-6736(12)60034-8.","journal-title":"Lancet"},{"issue":"5","key":"449_CR4","doi-asserted-by":"publisher","first-page":"456","DOI":"10.2174\/156802612799362922","volume":"12","author":"VM Zhang","year":"2012","unstructured":"Zhang VM, Chavchich M, Waters NC: Targeting protein kinases in the malaria parasite: update of an antimalarial drug target. Curr Top Med Chem. 2012, 12 (5): 456-472. 10.2174\/156802612799362922.","journal-title":"Curr Top Med Chem"},{"issue":"4","key":"449_CR5","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S1473-3099(13)70005-7","volume":"13","author":"P Bejon","year":"2013","unstructured":"Bejon P, White MT, Olotu A, Bojang K, Lusingu JP, Salim N, Otsyula NN, Agnandji ST, Asante KP, Owusu-Agyei S, Abdulla S, Ghani AC: Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data. Lancet Infect Dis. 2013, 13 (4): 319-327. 10.1016\/S1473-3099(13)70005-7.","journal-title":"Lancet Infect Dis"},{"key":"449_CR6","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/1475-2875-11-372","volume":"11","author":"KS Vannice","year":"2012","unstructured":"Vannice KS, Brown GV, Akanmori BD, Moorthy VS: MALVAC 2012 scientific forum: accelerating development of second-generation malaria vaccines. Malar J. 2012, 11: 372-10.1186\/1475-2875-11-372.","journal-title":"Malar J"},{"issue":"6","key":"449_CR7","doi-asserted-by":"publisher","first-page":"465","DOI":"10.7883\/yoken.65.465","volume":"65","author":"T Mita","year":"2012","unstructured":"Mita T, Tanabe K: Evolution of Plasmodium falciparum drug resistance: implications for the development and containment of artemisinin resistance. Jpn J Infect Dis. 2012, 65 (6): 465-475. 10.7883\/yoken.65.465.","journal-title":"Jpn J Infect Dis"},{"issue":"12","key":"449_CR8","doi-asserted-by":"publisher","first-page":"e52236","DOI":"10.1371\/journal.pone.0052236","volume":"7","author":"P Starzengruber","year":"2012","unstructured":"Starzengruber P, Swoboda P, Fuehrer HP, Khan WA, Hofecker V, Siedl A, Fally M, Graf O, Teja-Isavadharm P, Haque R, Ringwald P, Noedl H: Current status of artemisinin-resistant falciparum malaria in South Asia: a randomized controlled artesunate monotherapy trial in Bangladesh. PLoS One. 2012, 7 (12): e52236-10.1371\/journal.pone.0052236.","journal-title":"PLoS One"},{"issue":"2","key":"449_CR9","doi-asserted-by":"publisher","first-page":"270","DOI":"10.2174\/138161213804070357","volume":"19","author":"JF Garcia-Bustos","year":"2013","unstructured":"Garcia-Bustos JF, Gamo FJ: Antimalarial drug resistance and early drug discovery. Curr Pharm Des. 2013, 19 (2): 270-281. 10.2174\/138161213804070357.","journal-title":"Curr Pharm Des"},{"issue":"3","key":"449_CR10","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1517\/14728222.11.3.279","volume":"11","author":"C Doerig","year":"2007","unstructured":"Doerig C, Meijer L: Antimalarial drug discovery: targeting protein kinases. Expert Opin Ther Targets. 2007, 11 (3): 279-290. 10.1517\/14728222.11.3.279.","journal-title":"Expert Opin Ther Targets"},{"issue":"3","key":"449_CR11","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2174\/138945007780058979","volume":"8","author":"F Canduri","year":"2007","unstructured":"Canduri F, Perez PC, Caceres RA, De Azevedo WF: Protein kinases as targets for antiparasitic chemotherapy drugs. Curr Drug Targets. 2007, 8 (3): 389-398. 10.2174\/138945007780058979.","journal-title":"Curr Drug Targets"},{"issue":"3","key":"449_CR12","doi-asserted-by":"publisher","first-page":"134","DOI":"10.2174\/187152610791163381","volume":"10","author":"D Jirage","year":"2010","unstructured":"Jirage D, Keenan SM, Waters NC: Exploring novel targets for antimalarial drug discovery: plasmodial protein kinases. Infect Disord Drug Targets. 2010, 10 (3): 134-146. 10.2174\/187152610791163381.","journal-title":"Infect Disord Drug Targets"},{"key":"449_CR13","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/1475-2875-12-116","volume":"12","author":"PT Mpangase","year":"2013","unstructured":"Mpangase PT, Szolkiewicz MJ, Le Grange M, Smit JH, Burger PB, Joubert F: Discovery-2: an interactive resource for the rational selection and comparison of putative drug target proteins in malaria. Malar J. 2013, 12: 116-10.1186\/1475-2875-12-116.","journal-title":"Malar J"},{"key":"449_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/978-1-62703-342-8_14","volume":"993","author":"KM Bullard","year":"2013","unstructured":"Bullard KM, DeLisle RK, Keenan SM: Malarial kinases: novel targets for in silico approaches to drug discovery. Methods Mol Biol. 2013, 993: 205-229. 10.1007\/978-1-62703-342-8_14.","journal-title":"Methods Mol Biol"},{"issue":"28","key":"449_CR15","doi-asserted-by":"publisher","first-page":"20558","DOI":"10.1074\/jbc.M113.482992","volume":"288","author":"Y Augagneur","year":"2013","unstructured":"Augagneur Y, Jaubert L, Schiavoni M, Pachikara N, Garg A, Usmani-Brown S, Wesolowski D, Zeller S, Ghosal A, Cornillot E, Said HM, Kumar P, Altman S, Ben Mamoun C: Identification and functional analysis of the primary pantothenate transporter, PfPAT, of the human malaria parasite Plasmodium falciparum. J Biol Chem. 2013, 288 (28): 20558-20567. 10.1074\/jbc.M113.482992.","journal-title":"J Biol Chem"},{"key":"449_CR16","volume-title":"A Selective Inhibitor of Plasmodium falciparum Glucose-6-Phosphate Dehydrogenase (PfG6PDH)","author":"P Maloney","year":"2011","unstructured":"Maloney P, Hedrick M, Peddibhotla S, Hershberger P, Milewski M, Gosalia P, Li L, Preuss J, Sugarman E, Hood B, Suyama E, Nguyen K, Vasile S, Sergienko E, Salanawil S, Stonich D, Su Y, Dahl R, Mangravita-Novo A, Vicchiarelli M, McAnally D, Smith LH, Roth G, Diwan J, Chung TDY, Pinkerton AB, Bode L, Becker K: A Selective Inhibitor of Plasmodium falciparum Glucose-6-Phosphate Dehydrogenase (PfG6PDH). 2011, U.S.A: Probe Reports from the NIH Molecular Libraries Program. National Center for Biotechnology Information"},{"issue":"13","key":"449_CR17","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.2174\/13895575113136660094","volume":"13","author":"AS Ramdhave","year":"2013","unstructured":"Ramdhave AS, Patel D, Ramya I, Nandave M, Kharkar PS: Targeting heat shock protein 90 for malaria. Mini Rev Med Chem. Bentham Science Publishers. U.S.A. 2013, 13 (13): 1903-1920. 10.2174\/13895575113136660094.","journal-title":"Mini Rev Med Chem. Bentham Science Publishers. U.S.A"},{"issue":"10","key":"449_CR18","doi-asserted-by":"publisher","first-page":"e1003257","DOI":"10.1371\/journal.pcbi.1003257","volume":"9","author":"A Spitzmuller","year":"2013","unstructured":"Spitzmuller A, Mestres J: Prediction of the P. Falciparum target space relevant to malaria drug discovery. PLoS Comput Biol. 2013, 9 (10): e1003257-10.1371\/journal.pcbi.1003257.","journal-title":"PLoS Comput Biol"},{"issue":"12","key":"449_CR19","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nrmicro3138","volume":"11","author":"EL Flannery","year":"2013","unstructured":"Flannery EL, Chatterjee AK, Winzeler EA: Antimalarial drug discovery - approaches and progress towards new medicines. Nat Rev Microbiol. 2013, 11 (12): 849-862. 10.1038\/nrmicro3138.","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"449_CR20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.molbiopara.2005.02.002","volume":"141","author":"F Seow","year":"2005","unstructured":"Seow F, Sato S, Janssen CS, Riehle MO, Mukhopadhyay A, Phillips RS, Wilson RJ, Barrett MP: The plastidic DNA replication enzyme complex of Plasmodium falciparum. Mol Biochem Parasitol. 2005, 141 (2): 145-153. 10.1016\/j.molbiopara.2005.02.002.","journal-title":"Mol Biochem Parasitol"},{"issue":"18","key":"449_CR21","doi-asserted-by":"publisher","first-page":"4699","DOI":"10.1111\/j.1742-4658.2007.06000.x","volume":"274","author":"R Tuteja","year":"2007","unstructured":"Tuteja R: Helicases - feasible antimalarial drug target for Plasmodium falciparum. Febs J. 2007, 274 (18): 4699-4704. 10.1111\/j.1742-4658.2007.06000.x.","journal-title":"Febs J"},{"issue":"1","key":"449_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2006.03.007","volume":"376","author":"R Tuteja","year":"2006","unstructured":"Tuteja R, Pradhan A: Unraveling the 'DEAD-box' helicases of Plasmodium falciparum. Gene. 2006, 376 (1): 1-12. 10.1016\/j.gene.2006.03.007.","journal-title":"Gene"},{"issue":"8","key":"449_CR23","doi-asserted-by":"publisher","first-page":"883","DOI":"10.2174\/092986707780362998","volume":"14","author":"XG Xi","year":"2007","unstructured":"Xi XG: Helicases as antiviral and anticancer drug targets. Curr Med Chem. 2007, 14 (8): 883-915. 10.2174\/092986707780362998.","journal-title":"Curr Med Chem"},{"issue":"6","key":"449_CR24","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1358\/dnp.2003.16.6.829307","volume":"16","author":"DN Frick","year":"2003","unstructured":"Frick DN: Helicases as antiviral drug targets. Drug News Perspect. 2003, 16 (6): 355-362. 10.1358\/dnp.2003.16.6.829307.","journal-title":"Drug News Perspect"},{"issue":"3","key":"449_CR25","doi-asserted-by":"publisher","first-page":"183","DOI":"10.2174\/1568011053765985","volume":"5","author":"S Sharma","year":"2005","unstructured":"Sharma S, Doherty KM, Brosh RM: DNA helicases as targets for anti-cancer drugs. Curr Med Chem Anticancer Agents. 2005, 5 (3): 183-199. 10.2174\/1568011053765985.","journal-title":"Curr Med Chem Anticancer Agents"},{"issue":"10","key":"449_CR26","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nrd1853","volume":"4","author":"AD Kwong","year":"2005","unstructured":"Kwong AD, Rao BG, Jeang KT: Viral and cellular RNA helicases as antiviral targets. Nat Rev Drug Discov. 2005, 4 (10): 845-853. 10.1038\/nrd1853.","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"449_CR27","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1177\/1087057113482586","volume":"18","author":"WR Shadrick","year":"2013","unstructured":"Shadrick WR, Ndjomou J, Kolli R, Mukherjee S, Hanson AM, Frick DN: Discovering new medicines targeting helicases: challenges and recent progress. J Biomol Screen. 2013, 18 (7): 761-781. 10.1177\/1087057113482586.","journal-title":"J Biomol Screen"},{"issue":"10","key":"449_CR28","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1517\/14728222.2013.827663","volume":"17","author":"SK Weller","year":"2013","unstructured":"Weller SK, Kuchta RD: The DNA helicase-primase complex as a target for herpes viral infection. Expert Opin Ther Targets. 2013, 17 (10): 1119-1132. 10.1517\/14728222.2013.827663.","journal-title":"Expert Opin Ther Targets"},{"issue":"1","key":"449_CR29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.drup.2010.11.002","volume":"14","author":"HJ Field","year":"2011","unstructured":"Field HJ, Biswas S: Antiviral drug resistance and helicase-primase inhibitors of herpes simplex virus. Drug Resist Updat. 2011, 14 (1): 45-51. 10.1016\/j.drup.2010.11.002.","journal-title":"Drug Resist Updat"},{"issue":"20","key":"449_CR30","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.4161\/cc.26320","volume":"12","author":"M Aggarwal","year":"2013","unstructured":"Aggarwal M, Banerjee T, Sommers JA, Brosh RM: Targeting an Achilles' heel of cancer with a WRN helicase inhibitor. Cell Cycle. 2013, 12 (20): 3329-3335.","journal-title":"Cell Cycle"},{"issue":"24","key":"449_CR31","doi-asserted-by":"publisher","first-page":"10896","DOI":"10.1021\/jm300922h","volume":"55","author":"B Li","year":"2012","unstructured":"Li B, Pai R, Di M, Aiello D, Barnes MH, Butler MM, Tashjian TF, Peet NP, Bowlin TL, Moir DT: Coumarin-based inhibitors of Bacillus anthracis and Staphylococcus aureus replicative DNA helicase: chemical optimization, biological evaluation, and antibacterial activities. J Med Chem. 2012, 55 (24): 10896-10908. 10.1021\/jm300922h.","journal-title":"J Med Chem"},{"issue":"11","key":"449_CR32","doi-asserted-by":"publisher","first-page":"e49385","DOI":"10.1371\/journal.pone.0049385","volume":"7","author":"M Ahmad","year":"2012","unstructured":"Ahmad M, Ansari A, Tarique M, Satsangi AT, Tuteja R: Plasmodium falciparum UvrD helicase translocates in 3' to 5' direction, colocalizes with MLH and modulates its activity through physical interaction. PLoS One. 2012, 7 (11): e49385-10.1371\/journal.pone.0049385.","journal-title":"PLoS One"},{"issue":"2","key":"449_CR33","doi-asserted-by":"publisher","first-page":"e23125","DOI":"10.4161\/cib.23125","volume":"6","author":"R Tuteja","year":"2013","unstructured":"Tuteja R: In silico analysis of Plasmodium species specific UvrD helicase. Communicative and Integrative Biology. 2013, 6 (2): e23125-10.4161\/cib.23125.","journal-title":"Communicative and Integrative Biology"},{"issue":"1","key":"449_CR34","doi-asserted-by":"publisher","first-page":"104","DOI":"10.4161\/cc.9.1.10241","volume":"9","author":"R Tuteja","year":"2010","unstructured":"Tuteja R: Genome wide identification of Plasmodium falciparum helicases: a comparison with human host. Cell Cycle. 2010, 9 (1): 104-120. 10.4161\/cc.9.1.10241.","journal-title":"Cell Cycle"},{"issue":"2","key":"449_CR35","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.gene.2007.12.015","volume":"410","author":"J Shankar","year":"2008","unstructured":"Shankar J, Tuteja R: UvrD helicase of Plasmodium falciparum. Gene. 2008, 410 (2): 223-233. 10.1016\/j.gene.2007.12.015.","journal-title":"Gene"},{"issue":"15","key":"449_CR36","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.1093\/nar\/gkl450","volume":"34","author":"SW Matson","year":"2006","unstructured":"Matson SW, Robertson AB: The UvrD helicase and its modulation by the mismatch repair protein MutL. Nucleic Acids Res. 2006, 34 (15): 4089-4097. 10.1093\/nar\/gkl450.","journal-title":"Nucleic Acids Res"},{"issue":"20","key":"449_CR37","doi-asserted-by":"publisher","first-page":"15114","DOI":"10.1074\/jbc.M701167200","volume":"282","author":"KM Sinha","year":"2007","unstructured":"Sinha KM, Stephanou NC, Gao F, Glickman MS, Shuman S: Mycobacterial UvrD1 is a Ku-dependent DNA helicase that plays a role in multiple DNA repair events, including double-strand break repair. J Biol Chem. 2007, 282 (20): 15114-15125. 10.1074\/jbc.M701167200.","journal-title":"J Biol Chem"},{"issue":"36","key":"449_CR38","doi-asserted-by":"publisher","first-page":"9355","DOI":"10.1021\/bi800725q","volume":"47","author":"KM Sinha","year":"2008","unstructured":"Sinha KM, Stephanou NC, Unciuleac MC, Glickman MS, Shuman S: Domain requirements for DNA unwinding by mycobacterial UvrD2, an essential DNA helicase. Biochemistry. 2008, 47 (36): 9355-9364. 10.1021\/bi800725q.","journal-title":"Biochemistry"},{"issue":"15","key":"449_CR39","doi-asserted-by":"publisher","first-page":"9197","DOI":"10.1074\/jbc.273.15.9197","volume":"273","author":"M Yamaguchi","year":"1998","unstructured":"Yamaguchi M, Dao V, Modrich P: MutS and MutL activate DNA helicase II in a mismatch-dependent manner. J Biol Chem. 1998, 273 (15): 9197-9201. 10.1074\/jbc.273.15.9197.","journal-title":"J Biol Chem"},{"issue":"32","key":"449_CR40","doi-asserted-by":"crossref","first-page":"23762","DOI":"10.1016\/S0021-9258(20)80446-3","volume":"268","author":"RM Schaaper","year":"1993","unstructured":"Schaaper RM: Base selection, proofreading, and mismatch repair during DNA replication in Escherichia coli. J Biol Chem. 1993, 268 (32): 23762-23765.","journal-title":"J Biol Chem"},{"issue":"12","key":"449_CR41","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1016\/j.bbapap.2013.10.010","volume":"1834","author":"M Ahmad","year":"2013","unstructured":"Ahmad M, Tuteja R: Plasmodium falciparum RuvB2 translocates in 5'-3' direction, relocalizes during schizont stage and its enzymatic activities are up regulated by RuvB3 of the same complex. Biochim Biophys Acta. 2013, 1834 (12): 2795-2811. 10.1016\/j.bbapap.2013.10.010.","journal-title":"Biochim Biophys Acta"},{"issue":"15","key":"449_CR42","doi-asserted-by":"publisher","first-page":"3545","DOI":"10.1111\/j.1742-4658.2006.05362.x","volume":"273","author":"A Pradhan","year":"2006","unstructured":"Pradhan A, Tuteja R: Plasmodium falciparum DNA helicase 60. dsRNA- and antibody-mediated inhibition of malaria parasite growth and downregulation of its enzyme activities by DNA-interacting compounds. Febs J. 2006, 273 (15): 3545-3556. 10.1111\/j.1742-4658.2006.05362.x.","journal-title":"Febs J"},{"key":"449_CR43","doi-asserted-by":"publisher","first-page":"e994","DOI":"10.1038\/cddis.2013.521","volume":"5","author":"M Panchal","year":"2014","unstructured":"Panchal M, Rawat K, Kumar G, Kibria KM, Singh S, Kalamuddin M, Mohmmed A, Malhotra P, Tuteja R: Plasmodium falciparum signal recognition particle components and anti-parasitic effect of ivermectin in blocking nucleo-cytoplasmic shuttling of SRP. Cell Death Dis. 2014, 5: e994-10.1038\/cddis.2013.521.","journal-title":"Cell Death Dis"},{"issue":"2","key":"449_CR44","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.bbrc.2009.01.165","volume":"381","author":"N Sriwilaijaroen","year":"2009","unstructured":"Sriwilaijaroen N, Boonma S, Attasart P, Pothikasikorn J, Panyim S, Noonpakdee W: Inhibition of Plasmodium falciparum proliferation in vitro by double-stranded RNA directed against malaria histone deacetylase. Biochem Biophys Res Commun. 2009, 381 (2): 144-147. 10.1016\/j.bbrc.2009.01.165.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"449_CR45","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1046\/j.1365-2958.2002.03105.x","volume":"45","author":"P Malhotra","year":"2002","unstructured":"Malhotra P, Dasaradhi PV, Kumar A, Mohmmed A, Agrawal N, Bhatnagar RK, Chauhan VS: Double-stranded RNA-mediated gene silencing of cysteine proteases (falcipain-1 and -2) of Plasmodium falciparum. Mol Microbiol. 2002, 45 (5): 1245-1254. 10.1046\/j.1365-2958.2002.03105.x.","journal-title":"Mol Microbiol"},{"issue":"2","key":"449_CR46","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jmb.2007.07.056","volume":"373","author":"A Pradhan","year":"2007","unstructured":"Pradhan A, Tuteja R: Bipolar, dual Plasmodium falciparum helicase 45 expressed in the intraerythrocytic developmental cycle is required for parasite growth. J Mol Biol. 2007, 373 (2): 268-281. 10.1016\/j.jmb.2007.07.056.","journal-title":"J Mol Biol"},{"issue":"11","key":"449_CR47","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.1093\/nar\/gkp239","volume":"37","author":"J Baum","year":"2009","unstructured":"Baum J, Papenfuss AT, Mair GR, Janse CJ, Vlachou D, Waters AP, Cowman AF, Crabb BS, De Koning-Ward TF: Molecular genetics and comparative genomics reveal RNAi is not functional in malaria parasites. Nucleic Acids Res. 2009, 37 (11): 3788-3798. 10.1093\/nar\/gkp239.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"449_CR48","doi-asserted-by":"publisher","first-page":"278","DOI":"10.2174\/13816128113199990027","volume":"20","author":"AK Mueller","year":"2013","unstructured":"Mueller AK, Hammerschmidt-Kamper C, Kaiser A: RNAi in Plasmodium. Curr Pharm Des. 2013, 20 (2): 278-283.","journal-title":"Curr Pharm Des"},{"issue":"3","key":"449_CR49","first-page":"333","volume":"20","author":"C Tan","year":"1967","unstructured":"Tan C, Tasaka H, Yu KP, Murphy ML, Karnofsky DA: Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia. Cancer. 1967, 20 (3): 333-353.","journal-title":"Clinical evaluation with special reference to childhood leukemia. Cancer"},{"issue":"8","key":"449_CR50","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1128\/AAC.32.8.1182","volume":"32","author":"AA Divo","year":"1988","unstructured":"Divo AA, Sartorelli AC, Patton CL, Bia FJ: Activity of fluoroquinolone antibiotics against Plasmodium falciparum in vitro. Antimicrob Agents Chemother. 1988, 32 (8): 1182-1186. 10.1128\/AAC.32.8.1182.","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"449_CR51","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1128\/AAC.00527-07","volume":"51","author":"EL Dahl","year":"2007","unstructured":"Dahl EL, Rosenthal PJ: Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplast. Antimicrob Agents Chemother. 2007, 51 (10): 3485-3490. 10.1128\/AAC.00527-07.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1689","key":"449_CR52","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1098\/rspb.2009.2176","volume":"277","author":"C Garcia-Estrada","year":"2010","unstructured":"Garcia-Estrada C, Prada CF, Fernandez-Rubio C, Rojo-Vazquez F, Balana-Fouce R: DNA topoisomerases in apicomplexan parasites: promising targets for drug discovery. Proc Biol Sci. 2010, 277 (1689): 1777-1787. 10.1098\/rspb.2009.2176.","journal-title":"Proc Biol Sci"},{"issue":"5","key":"449_CR53","doi-asserted-by":"publisher","first-page":"e00072","DOI":"10.1042\/BSR20130083","volume":"33","author":"N Simon","year":"2013","unstructured":"Simon N, Bochman ML, Seguin S, Brodsky JL, Seibel WL, Schwacha A: Ciprofloxacin is an inhibitor of the Mcm2-7 Replicative Helicase. Biosci Rep. 2013, 33 (5): e00072-","journal-title":"Biosci Rep"},{"issue":"3","key":"449_CR54","doi-asserted-by":"publisher","first-page":"e90951","DOI":"10.1371\/journal.pone.0090951","volume":"9","author":"A Ansari","year":"2014","unstructured":"Ansari A, Tarique M, Tuteja R: Genetically engineered synthetic miniaturized versions of Plasmodium falciparum UvrD helicase Are catalytically active. PLoS One. 2014, 9 (3): e90951-10.1371\/journal.pone.0090951.","journal-title":"PLoS One"}],"container-title":["BMC Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2091-15-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T03:17:13Z","timestamp":1630552633000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbiochem.biomedcentral.com\/articles\/10.1186\/1471-2091-15-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,3]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["449"],"URL":"https:\/\/doi.org\/10.1186\/1471-2091-15-9","relation":{},"ISSN":["1471-2091"],"issn-type":[{"value":"1471-2091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,3]]},"assertion":[{"value":"22 January 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"9"}}